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The current study aimed to determine the prevalence of Extended-Spectrum
-Lactamases (ESBLs) in Escherichia coli (E. coli) and Klebsiella pneumoniae
(K. pneumoniae) strains isolated from patients with Urinary Tract Infections (UTIs), to
study the association between presence of ESBL enzyme and multi-drug resistance strains
and finally, and to investigate the predominant ESBL gene in E. coli and K. pneumoniae.
The strains were examined for the presence of ESBL as a Clinical Laboratory Standards
Institute (CLSI) guideline.  Among 284 clinical isolates, 52.8% (n = 150) and 47.2%
(n =134) were E. coli and K. pneumoniae, respectively, and 110 strains were ESBL
producer, which 68 strains were K. pneumoniae and 42 strains were E. coli. Significant
difference observed between the TEM gene and ciprofloxacin resistant in E. coli
(P  0.05) while no significant difference observed between CTX-M, SHV genes and the
other multi-drug resistant E. coli. No significant difference observed between CTX-M,
TEM, and SHV genes and multi-drug resistant K. pneumoniae. In conclusion, spreading
of ESBL-producing strains is a concern, as it causes limitations to the antimicrobial
agents for optimal treatment of patients. Prevalence of ESBLs was more observed in K.
pneumoniae than E. coli. In addition, TEM gene was more prevalent in E. coli and
resistance to ciprofloxacin was predominant in E. coli.
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Antimicrobial resistance is a worldwide
concern and responsible for distribution of
infections.  Resistance to -lactam antibiotics is
associated with the presence of ESBL. Production
of ESBLs was found to be one of the most important
mechanisms for resistance to -lactam antibiotics.
ESBLs producer bacteria are resistant to the third-
generation cephalosporins. During the last two
decades, ESBL producing Gram-negative bacilli
have emerged as a major problem in hospital
settings1.
In addition, ESBL is mediated resistant to
broad-spectrum cephalosporins (e.g., ceftazidime,
ceftriaxone, and cefotaxime) and aztreonam2.
ESBLs are mutant, plasmid-mediated beta-
lactamases derived from older, broad-spectrum
beta-lactamases (e.g., TEM-1, TEM-2, and SHV-1),
have an extended substrate profile, which allows
hydrolysis of all cephalosporins, penicillins, and
aztreonam3. These enzymes are most commonly
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proteins that were produced by Klebsiella spp.
and E. coli. Failure to detect ESBL produced
bacteria by routine disk-diffusion tests has been
well-documented4.
In the other hand, UTI is the one of the
most common infection diseases in humans. E. coli
and K. pneumoniae are found as an important
pathogenic microorganism in UTI.
Resistance to -lactame antibiotics is
mainly mediated by the production of diverse set
of enzymes that the most important are ESBLs and
Metallo -lactameses. Studies revealed that by use
of the third generation of cephalosprins led to the
multidrug resistance and producing of ESBL
bacteria.
There are diverse set of enzymes, which
are responsible for producing ESBL including
TEM, SHV and CTX-M.
In recent years, resistance to different
antibiotics has raised dramatically leaving
physicians with few therapeutic options. Rates of
resistance to antibiotics differ from region to region,
in making an appropriate choice of empiric or
definitive therapy for UTI; it is useful to avail of
information on prevailing levels of antimicrobial
resistance among common urinary pathogens.
Treatment of UTI cases is often started
empirically. Therapy is based on information
determined from the antimicrobial resistance pattern
of the urinary pathogens. However, because of
the evolving and continuing antibiotic resistance
phenomenon, regular monitoring of resistance
patterns is necessary to improve guidelines for
empirical antibiotic therapy.
The current study aimed to determine the
prevalence of ESBLs in E. coli and K. pneumoniae
strains isolated from patients with UTI, to study
association between presence of ESBL and multi-
drug resistance bacteria and, to investigate
predominant gene responsible for ESBLs
production in E. coli and K. pneumoniae.
MATERIALS   AND  METHODS
A prospective study was conducted over
a period of one year (March 2007 to April 2008 (in
Milad hospital in capital of Iran,(the strains
collected from in-patients and out-patients. Strains
were identified, based on the standard
bacteriological techniques and were tested for
presence of ESBL enzyme by using the
combination disk method recommended by CLSI5.
Combination disk method
The combination-disk test using both
cefotaxime and ceftazidime, alone and in
combination with clavulanic acid, was performed
for the detection of ESBL according to the CLSI
guidelines. Overnight culture suspension of the
0.5 McFarland of tested bacteria inoculated to
Mueller Hinton Agar plate. Cefotaxime (30 µg) and
cefotaxime-clavulanic acid (30 µg/ 10 µg) disks were
placed 20 mm apart on the agar plate. Similarly, the
ceftazidime (30 µg) and ceftazidime-clavulanic acid
(30 µg/10 µg) disks were placed 20 mm apart. After
incubating overnight at 37oC, a  5-mm increase in
the zone diameter for either antimicrobial agent,
which were tested in combination with clavulanic
acid, its zone when tested alone, was interpreted
as positive for ESBL enzyme5.
Antibiotic susceptibility testing
Susceptibility of the ESBL producing
bacteria to amikacin, cotrimoxazol and ciprofloxacin
was determined by the Kirby-Bauer disk diffusion
method according to the CLSI guideline6.
Quality Control
K. pneumoniae ATCC 700603 and E. coli
ATCC 25922 were positive and negative quality
control for presence of ESBL, respectively. E.coli
Table 1. Primers used in PCR for identification of ESBLs genes
ESBLs Genes Primers References
TEM Forward 5’-GAGTATCAACATTTCCGTGTC-3’ 7
Reverse 5’-TAATCAGTGAGGCACCTTCTC-3’
SHV Forward: 5’–AAGATCCACTATCGCCCAGCAG-3’ 7
Reverse 5’-AAGATCCACTATCGC CCAGCAG-3’
CTX-M Forward 5’-ACGCTGTTGTTAGGAAGTG-3’ 7
Reverse 5’-TTGAGGCTGGGTGAAGT-3’
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ATCC 25922 was used for the quality control of
the Kirby-Bauer disk diffusion method.
PCR Amplification
PCR analysis for -lactamase genes of the
family blaTEM, CTX-M and SHV was carried out.
The Primers used for SHV, TEM and CTX-
M genes are listed in Table 1.
Statistical analysis
Chi-square test by SPSS16 was used with
appropriate correction for the observation and for
the significant difference between the ESBLs
positive strains and multi-drug resistant K.
pneumonia and E. coli. P  0.05 was considered
significant.
RESULTS
A total of 284 isolates were tested for
presence of ESBL during a period of one year.
Among 284 strains, 52.8% (n = 150) and 47.2%
(n =134) were E. coli and K. pneumoniae,
respectively. Overall, 38.7% (n = 110) of the strains
were ESBLs positive, which K. pneumoniae with
50.74% (n = 68) positive strains showed higher
prevalence than E. coli with 28% (n = 42).
Of the 68 ESBL positive K. pneumoniae
strains, 4 strains harbored TEM gene, 14 strains
carried CTX-M gene and 57 strains carried SHV
genes as detected by PCR and among 42 ESBL
positive E. coli strains, 40 strains showed positive
results for TEM gene, 6  strains harbored CTX-M
gene  and 12 possessed SHV gene.
While some ESBLs confer high-level of
resistance to all oxyimino-cephalosporins, for other
ESBLs, resistance may only be slightly increased
or selectively affected in certain -lactams.
Antibiotic susceptibility pattern of uro-pathogens
were as follows:
E. coli: Cotrimoxazole (43%), amikacin
(38%) and ciprofloxacin (57.1%).
K. pnemoniae: Cotrimoxazole (38%),
amikacin (36.7%) and ciprofloxacin (23.5%).
In E. coli, significant difference observed
between TEM gene and resistance to ciprofloxacin
(P d” 0.05) while no significant difference observed
between CTX-M, SHV genes and multi-drug
resistance strains. No significant difference
observed between CTX-M TEM, and SHV genes
and multi-drug resistant K. pneumoniae.
DISCUSSION
Antibiotic sensitivity pattern of
organisms are changing rapidly over a short period.
It is especially consistent for developing country
where antibiotics are prescribed irrationally not
only by the medical practitioners but the antibiotics
are also purchased directly from the chemist
(Medicine shop keepers) without prescription.
Resistance to extended spectrum
cephalosporins is mainly mediated by the
production of ESBLs. Recent studies on ESBL
producer bacteria in Enterobacteriaceae, which
were isolated from clinical specimens, showed an
increase in the occurrence of ESBL producers8. In
a similar study by Mathur et al, 62% of the E. coli
and 73% of the K. pneumoniae strains were
reported to be ESBL producers9.
In the present study, we observed 28%
of the E. coli and 50.74 % of the K. pneumoniae
strains were ESBL producers. In addition, studies
also reported that K. pneumoniae were more
reported as ESBL producers than E. coli10,11.
The findings of current research revealed
that SHV was more observed in K. pneumoniae
while the prevalence of TEM gene in E. coli was
not comparable. The results showed that the
lowest frequency of CTX-M occurred in E .coli.
Interestingly, our finding presented multi-
drug resistant E. coli strains were more than K.
pneumoniae strains. Ciprofloxacin resistant E. coli
was predominant and the lowest resistance to
ciprofloxacin observed in K. pneumoniae. The
reason could be explained by gene responsible for
ciprofloxacin resistant that it may confer by plasmid
harboring TEM gene. In our study, the most active
antibiotic against ESBLs producer strains was
amikacin and ciprofloxacin was found as a best
antibiotic for treatment of K. pneumoniae
producing ESBL.
ESBL producing organisms, being the
commonest nosocomial pathogens, it is essential
to detect and treat them as early as possible. Since
ESBL producer bacteria is more common among
the nosocomial pathogens, early detection will
definitely help in controlling hospital infections.
Enterobacteriaceae are the common
isolates in most of the laboratories. Now a days, a
majority of these isolates are multi-drug resistance.
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The control of these multi-drug resistance
organisms is a therapeutic challenge.
Study by Ghafourian et al., showed 43.9%
of K. pneumoniae was ESBL producers in Imam
Reza Hospital in Tabriz, which was lower than our
report in K .pneumoniae. Resistance rate to
amikacin, ciprofloxacin and cotrimoxazol in Imam
Reza hospital was less than the results, which
obtained in our study12.
In the study a tertiary care hospital in
Tehran 77% of K.pneumoniae were ESBLs
producer13 while in our study frequency of ESBL
positive strains were lower. In a survey by bazzaz
et al., in 2007 in general hospitals in Iran, 59.2% of
isolates were positive for ESBL, our findings in
Milad hospital revealed near results to bazzaz et
al.14. The prevalence of ESBL producers among
the 131 clinical isolates was found to be 28% for E.
coli and 50.74% for K. pneumoniae. The report of
ESBL occurrence among uro-pathogenic E. coli
and K. pneumoniae in India were known to be 40
and 54.54%, respectively15. The ESBL positive
isolates of E. coli and K. pneumoniae were found
to be multidrug resistance. Our findings is
corresponding with Bhowmick and Rashid
results16.
In conclusion, spreading of ESBL-
producing strains is a concern, as it causes
limitations to the antimicrobial agents for optimal
treatment of patients. Prevalence of ESBLs was
more among K .pneumoniae and TEM was more
observed in E. coli. Interestingly, Resistance to
ciprofloxacin was predominant in E. coli.
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